Venezuela Issues Health Alert Over Falsified Cough Syrup With Forged 2028 Expiry Date

Venezuela’s health institute flagged a falsified batch of cough syrup this week after discovering its expiration date had been forged to read 2028 instead of the real 2025 expiry.

The Instituto Nacional de Higiene Rafael Rangel (INHRR) issued Sanitary Alert ALSA-PE-2026-018 covering the entire national territory, warning that lot 22073A of Perebron 28 mg/5 mL honey-lemon syrup — registered under Sanitary Registry EF 41.148/22 and manufactured by Laboratorios Elmor, S.A, according to Noticia al Dia. — is being sold illegally with altered packaging, Noticia al Dia reported.

The manufacturer confirmed the original production date was September 2022 with a legitimate expiry of September 2025, meaning the product has been expired for over a year.

“The units detected in the market present erasure of the original marking both on the box and the bottle, deterioration of the secondary packaging and a false overprint indicating an expiration date of May 12, 2028,” the health ministry said in its official Instagram bulletin, Primicia reported.

The Ministry of Popular Power for Health (MPPS) disseminated the INHRR alert through its social channels, urging the public not to acquire, dispense, or consume the identified lot.

Venezuela Issues Health Alert Over Falsified Cough Syrup With Forged 2028 Expiry Date
Photo: primicia.com.ve

Syrup Lot 22073A Expired in 2025, Relabeled with Fake 2028 Date

  • The syrup in this specific lot (22073A) expired in September 2025; criminals scraped off the real dates and printed a fake 2028 date.
  • Expired guaifenesin can degrade into compounds that irritate the stomach and may fail to thin mucus, leaving a cough untreated.
  • Buy medicines only from licensed pharmacies; check for tampered boxes, mismatched fonts on dates, and broken safety seals.

How the Counterfeit Entered the Supply Chain

Laboratorios Elmor, S.A., the marketing authorization holder, verified the tampering after the INHRR submitted samples for technical comparison. The fraudulent overprint used a different font and alignment than the original factory coding, a detail pharmacists can spot under good lighting.

Ultima Noticias reported the same ministry bulletin, confirming the alert number and the specific lot details. Neither the INHRR nor the ministry has disclosed how many units have been seized or which regions have reported the falsified stock, leaving the geographic scope of the infiltration unclear.

Clinical Risks of Expired Guaifenesin Syrup

Perebron’s active ingredient, guaifenesin, is an expectorant that works by increasing hydration of respiratory tract secretions, reducing viscosity through stimulation of gastric vagal receptors. In a sealed, unopened bottle stored at controlled room temperature, guaifenesin remains chemically stable for the labeled shelf life.

Once past expiry — especially after 14 months — hydrolysis can lower the active concentration below the therapeutic threshold of 28 mg per 5 mL, while microbial growth in the aqueous syrup base poses a contamination risk.

Parameter Legitimate Lot 22073A Falsified Presentation
Manufacture Date September 2022 Erased / Overprinted
True Expiry September 2025 May 12, 2028 (fraudulent)
Packaging Integrity Intact factory seals Deteriorated secondary box, erased markings
Regulatory Status Expired, not for sale Illegal counterfeit

Report Suspicious Perebron Units to INHRR; No Adverse Events Yet

The alert instructs citizens, pharmacies, and distributors to report suspicious units immediately to the INHRR and corresponding health authorities. No adverse event reports linked to this lot have been published as of the alert date.

Parallel advisories from the Pan American Health Organization (PAHO) emphasize that substandard and falsified medical products disproportionately affect low- and middle-income countries, where supply chain monitoring resources are constrained. The Perebron case illustrates the “re-labeling” fraud modality — altering expiry dates on genuine but expired stock — which WHO classifies as a falsified medical product under its 2017 definitions.

Founded by executive decree on October 17, 1938, under President Eleazar López Contreras, the Instituto Nacional de Higiene Rafael Rangel serves as Venezuela’s national reference institute for sanitary control, product registration, and epidemic surveillance in bacteriology, virology, and mycology.

Originally located in the San Juan parish, it moved to its current headquarters at Ciudad Universitaria in 1951 and was renamed in 1977 to honor the scientist Rafael Rangel. The institute also produces vaccines, culture media, and laboratory reagents, operating under the Ministerio del Poder Popular para la Salud.

Do Not Use Perebron Lot 22073A; Quarantine and Report to INHRR

  • Do not acquire, dispense, or consume Perebron syrup from lot 22073A, as health authorities warn it is counterfeit and expired.
  • Pharmacists who identify units with mismatched box-and-bottle dates, smudged printing, or damaged tamper-evident seals must quarantine the stock and notify the INHRR.

The ministry reiterated that medicines should be purchased exclusively from authorized pharmaceutical establishments and verified for packaging integrity, seals, markings, and expiration dates before administration, Primicia noted.

References

  • Instituto Nacional de Higiene Rafael Rangel. Sanitary Alert ALSA-PE-2026-018. 2026.
  • Ministerio del Poder Popular para la Salud (MPPS). Official Instagram bulletin on Perebron lot 22073A. 2026.
  • World Health Organization. Definitions of substandard and falsified medical products. WHO Technical Report Series, No. 1025, 2017.
  • Pan American Health Organization. Substandard and falsified medical products: regional overview. PAHO, 2023.
  • BP 2024.

Photo of author

Health Desk

Health Desk at Archyde.

Arizona Rallies to Beat Kansas State 35-28 in Overtime for Fifth Straight Loss

Bus Driver Used Phone While Driving; Authority and Operator Confirm Consequences